Enabling the Immune Escaped Etesevimab Fully-Armed Against SARS-CoV-2 Omicron Subvariants Including KP.2

Chao Su, Juanhua He,Yufeng Xie,Yu Hu,Xin Li,Shitong Qiao, Peipei Liu,Min Huang,Rong Zhang,Liang Wang, Zhen Chang,Wenqiao Sun,Ke Xu,Jing Zhang,Longxing Cao,Pengcheng Han,Xin Zhao,Jianxun Qi,Qihui Wang,Mengsu Yang

hLife（2025）

Cited 0|Views3

Key words

etesevimab (CB6),severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),receptor-binding domain (RBD),broad-spectrum and affinity-mature antibody design (BAADesign),antibody

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined